There was no significant difference between younger (n = 9) and older (n = 3) cohorts of healthy controls in their GH response to 60 mg baclofen, and there was no association between age and GH response in our control sample (R2 = 0.0671) so the absence of a response in AD group is not age-related. The gene discussed is GH1; the disease is Alzheimer disease.